Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyung Sook | - |
dc.contributor.author | Lee, Jae Seob | - |
dc.contributor.author | Lee, Hong Kyung | - |
dc.contributor.author | Park, Eun Jae | - |
dc.contributor.author | Jeon, Hye Won | - |
dc.contributor.author | Kang, Yu Jeong | - |
dc.contributor.author | Lee, Tae Yong | - |
dc.contributor.author | Kim, Kyung Suk | - |
dc.contributor.author | Bae, Sang-Cheol | - |
dc.contributor.author | Park, Ji Hyun | - |
dc.contributor.author | Han, Sang-Bae | - |
dc.date.accessioned | 2021-08-02T10:52:41Z | - |
dc.date.available | 2021-08-02T10:52:41Z | - |
dc.date.issued | 2019-10 | - |
dc.identifier.issn | 1598-2629 | - |
dc.identifier.issn | 2092-6685 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/12477 | - |
dc.description.abstract | Mesenchymal stem cells (MSCs) ameliorate the renal injury in Adriamycin (ADR)-induced nephropathy, but the mechanisms underlying their efficacy remain incompletely understood. In this study, we demonstrated that MSCs increased the survival, recovered body weight loss, and decreased proteinuria and serum creatinine levels in ADR-treated mice. MSCs also prevented podocyte damage and renal fibrosis by decreasing the expression of fibronectin, collagen 1 alpha 1, and alpha-smooth muscle actin. From a mechanistic perspective, MSCs inhibited renal inflammation by lowering the expression of CCL4, CCL7, CCL19, IFN-alpha/beta, TGF-beta, TNF-alpha, and chitinase 3-like 1. In summary, our data demonstrate that MSCs improve renal functions by inhibiting renal inflammation in ADR-induced nephropathy. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREA ASSOC IMMUNOLOGISTS | - |
dc.title | Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4110/in.2019.19.e36 | - |
dc.identifier.scopusid | 2-s2.0-85074670190 | - |
dc.identifier.wosid | 000494964600007 | - |
dc.identifier.bibliographicCitation | IMMUNE NETWORK, v.19, no.5 | - |
dc.citation.title | IMMUNE NETWORK | - |
dc.citation.volume | 19 | - |
dc.citation.number | 5 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002520803 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.subject.keywordPlus | PODOCYTE INJURY | - |
dc.subject.keywordPlus | STROMAL CELLS | - |
dc.subject.keywordPlus | KIDNEY | - |
dc.subject.keywordPlus | ATTENUATE | - |
dc.subject.keywordPlus | FIBROSIS | - |
dc.subject.keywordPlus | RECOVERY | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | PROTECT | - |
dc.subject.keywordPlus | REPAIR | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordAuthor | Mesenchymal stem cells | - |
dc.subject.keywordAuthor | Inflammation | - |
dc.subject.keywordAuthor | Podocytes | - |
dc.subject.keywordAuthor | Fibrosis | - |
dc.identifier.url | https://immunenetwork.org/DOIx.php?id=10.4110/in.2019.19.e36 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.